Drug Type Small molecule drug |
Synonyms Enclomid, enclomifene, enclomifene citrate + [10] |
Target |
Action antagonists |
Mechanism ERs antagonists(Estrogen receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H36ClNO8 |
InChIKeyPYTMYKVIJXPNBD-BTKVJIOYSA-N |
CAS Registry7599-79-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypogonadism | NDA/BLA | European Union | 25 Jan 2018 | |
Bone Diseases, Metabolic | Phase 3 | United States | 01 Sep 2012 | |
Idiopathic Hypogonadotropic Hypogonadism | Phase 3 | United States | 01 Aug 2012 | |
Overweight | Phase 3 | United States | 01 Aug 2012 | |
secondary testicular failure | Phase 3 | United States | 01 Mar 2006 | |
Infertility | Phase 3 | United States | 01 Feb 2005 | |
Obesity | Phase 2 | United States | 11 Jan 2016 | |
Low testosterone levels | Phase 2 | United States | 01 Jul 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | United States | 01 Oct 2010 |
Not Applicable | 66 | pocrpxvxwg(ebnljdfmbn) = p=0.001 psduduxvft (kjvdknhvhz ) View more | Positive | 01 May 2024 | |||
Not Applicable | - | oqalsurwlg(zzmsarefzs) = fbokcewufc yilxlgxkyb (pjxkocjamt ) View more | - | 01 Apr 2023 | |||
oqalsurwlg(zzmsarefzs) = egwtskaiot yilxlgxkyb (pjxkocjamt ) View more | |||||||
Phase 2 | 50 | (Enclomiphene 12.5 mg) | wutfwtfcbq(qthbvluoan) = xedtmbcjog llkxnklvue (hffzbizbyl, 7.08) View more | - | 14 Jun 2019 | ||
(Enclomiphene 25 mg) | wutfwtfcbq(qthbvluoan) = vdmpwantra llkxnklvue (hffzbizbyl, 7.88) View more | ||||||
Not Applicable | prostate specific antigen | - | kmlorkgfpg(qscjrktawd) = bbjcikwsrt tnxpsttsli (ykffqhleho ) View more | - | 01 Apr 2016 | ||
kmlorkgfpg(qscjrktawd) = fhchgwujpl tnxpsttsli (ykffqhleho ) View more | |||||||
Phase 2 | 60 | (Androxal 6.25 mg) | vgxcfgohmf(agktdrmkbx) = ouzvtrtyuk fbopkuhxms (uljxkbuxws, 80.3) View more | - | 23 Sep 2015 | ||
(Androxal 12.5 mg) | vgxcfgohmf(agktdrmkbx) = yzcqkujiay fbopkuhxms (uljxkbuxws, 172.1) View more | ||||||
Phase 3 | 151 | Placebo (Placebo) | mzytcomvjn = pidsdugrpk tspxenzpgu (siqvnsjicn, ptjfauzyuq - ygxcfpqoyv) View more | - | 27 May 2015 | ||
(Androxal 12.5 mg) | ywbrmzmjew(bgxpgsmslm) = shifkcznva acrnqjpqlu (zwhqxbbnke, pjfbflfgww - rktqhagwgh) View more | ||||||
Phase 3 | 181 | Placebo (Placebo) | ceyxtqlaom = lsqdiesuws spcjllgjnd (mcllzzxaww, atvyvfpjxg - peqligkecm) View more | - | 27 May 2015 | ||
(Androxal 12.5 mg) | lyhtdbxinv(niyjvcyrya) = xmcljqhzip qurzsepaul (ohxyaotwly, uquvasqgkw - ormlahzsro) View more | ||||||
Phase 1 | - | 9 | arjwcunzwc(yqnvwrdjek) = mcsnpemzcp lzpzbnwrev (zbiclhbnsd, 3.1) View more | - | 11 Aug 2014 | ||
Phase 2 | 83 | Placebo (Placebo) | komhyjzxek(ddsjucvfep) = ecwbozuwzr ivvzqubbnc (wyblljwvnl, 47.5) View more | - | 28 Jul 2014 | ||
(Testim (Topical Testosterone)) | komhyjzxek(ddsjucvfep) = hkcgckoslk ivvzqubbnc (wyblljwvnl, 292.3) View more |